Finance

Beta
Lists
SZLSF:OTCMKTS
StageZero Life Sciences Ltd
$0.0051
0.00%
(0.00) 1D
Mar 24, 12:32:22 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SZLSF...
Mkt. cap
4.91M
Volume
0.00
52-wk high
$0.03
52-wk low
$0.00
Shares outstanding
123.55M
No. of employees
40
Mkt. cap
4.91M
Volume
0.00
52-wk high
$0.03
52-wk low
$0.00
Shares outstanding
123.55M
No. of employees
40
News stories
From sources across the web
About StageZero Life Sciences Ltd
CEO-
Employees40
Founded1997
HeadquartersRichmond Hill, Ontario, Canada
SectorBiotechnology
Websitestagezerolifesciences.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2024
Jun 2024
Sep 2024
Revenue
521.92K
390.08K
499.66K
Cost of goods sold
221.38K
382.26K
608.85K
Cost of revenue
221.38K
382.26K
608.85K
Research and development expenses
-
-
-
Total research and development expenses
-
-
-
Selling, general, and admin expenses
596.15K
703.10K
242.93K
Operating expense
596.15K
703.10K
242.93K
Total operating expenses
817.53K
1.09M
851.78K
Operating income
-295.60K
-695.28K
-352.12K
Other non operating income
-49.99K
98.49K
-
EBT including unusual items
-386.35K
-649.46K
-399.28K
EBT excluding unusual items
-386.35K
-649.46K
-399.28K
Income tax expense
-
-
-
Effective tax rate
-
-
-
Other operating expenses
-
-
-
Net income
-386.35K
-649.46K
-399.28K
Net profit margin
-74.02%
-166.49%
-79.91%
Earnings per share
-
-
-
Interest and investment income
-
-
-
Interest expense
-40.75K
-52.67K
-47.16K
Net interest expenses
-40.75K
-52.67K
-47.16K
Depreciation and amortization charges
-
-
-
EBITDA
-277.33K
-651.47K
-337.00K
Gain or loss from assets sale
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer